Comments
Loading...
Intellia Therapeutics Insider Trading Activity | NASDAQ:NTLA | Benzinga
Track the latest Intellia Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Intellia Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Intellia Therapeutics Inc Insiders Doing?
At Intellia Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of - shares worth -, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On January 31, 2025, Muna Bhanji, the company's - sold 265 shares for $9.97 each.
- On January 7, 2025, Michael Dube, the company's VP, CHIEF ACCOUNTING OFFICER sold 1.37K shares for $12.18 each.
- On January 7, 2025, Derek Hicks, the company's EVP, CHIEF BUSINESS OFFICER sold 6.5K shares for $12.18 each.
Ownership Statistics for Intellia Therapeutics Inc
Shares Outstanding
103.517M
Insider Shares Owned
2.994M
Insider Percentage Owned
2.89%
Institutional Shares Held
67.949M
Institutional Percentage Held
65.6%
| Mar 04, 2025 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | 31.32K | $8.99 | -$6.10K | GRANT | 48.90% | 95.37K | Mar 01 - Mar 04 | View |
| Mar 04, 2025 | James Basta | EVP, GENERAL COUNSEL | 37.43K | $8.99 | -$23.12K | GRANT | 50.24% | 111.92K | Mar 01 - Mar 04 | View |
| Jan 31, 2025 | Muna Bhanji | — | -265.00 | $9.97 | -$2.64K | SELL | -1.34% | 19.47K | Jan 29 | View |
| Jan 07, 2025 | Michael Dube | VP, CHIEF ACCOUNTING OFFICER | -1.37K | $12.18 | -$16.71K | SELL | -2.92% | 45.64K | Jan 03 | View |
| Jan 07, 2025 | James Basta | EVP, GENERAL COUNSEL | -7.07K | $12.18 | -$86.16K | SELL | -8.67% | 74.50K | Jan 03 | View |
| Jan 07, 2025 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | -9.56K | $12.18 | -$116.40K | SELL | -9.83% | 87.67K | Jan 03 | View |
| Jan 07, 2025 | Derek Hicks | EVP, CHIEF BUSINESS OFFICER | -6.50K | $12.18 | -$79.19K | SELL | -9.80% | 59.88K | Jan 03 | View |
| Jan 07, 2025 | JOHN LEONARD | PRESIDENT AND CEO | -26.81K | $12.18 | -$326.51K | SELL | -2.61% | 999.53K | Jan 03 | View |
| Jan 07, 2025 | Laura SeppLorenzino | EVP, CHIEF SCIENTIFIC OFFICER | -8.97K | $12.18 | -$109.21K | SELL | -10.38% | 77.39K | Jan 03 | View |
| Jan 06, 2025 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | -7.98K | $12.17 | -$97.09K | SELL | -11.08% | 64.05K | Jan 02 - Jan 03 | View |
| Oct 04, 2024 | Michael Dube | VP, CHIEF ACCOUNTING OFFICER | -2.01K | $19.01 | -$38.25K | SELL | -4.10% | 47.01K | Oct 02 | View |
| Jul 03, 2024 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | -405.00 | $22.93 | -$9.29K | SELL | -0.56% | 71.47K | Jul 01 | View |
| Jun 20, 2024 | Frank Verwiel | — | -1.50K | $25.00 | -$37.63K | SELL | -7.74% | 17.95K | Jun 17 | View |
| Mar 05, 2024 | James Basta | EVP, GENERAL COUNSEL | 30.10K | $32.99 | -$75.78K | GRANT | 58.47% | 81.57K | Mar 01 - Mar 04 | View |
| Mar 05, 2024 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | 30.63K | $32.99 | -$19.96K | GRANT | 74.98% | 71.47K | Mar 01 - Mar 04 | View |
| Jan 10, 2024 | Laura SeppLorenzino | EVP, CHIEF SCIENTIFIC OFFICER | -2.27K | $28.87 | -$65.68K | SELL | -4.92% | 43.93K | Jan 08 | View |
| Jan 05, 2024 | JOHN LEONARD | PRESIDENT AND CEO | -19.22K | $29.46 | -$566.31K | SELL | -2.08% | 904.90K | Jan 03 | View |
| Jan 05, 2024 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | -5.84K | $29.46 | -$172.13K | SELL | -9.70% | 54.37K | Jan 03 | View |
| Jan 05, 2024 | Laura SeppLorenzino | EVP, CHIEF SCIENTIFIC OFFICER | -5.53K | $29.46 | -$162.97K | SELL | -10.69% | 46.20K | Jan 03 | View |
| Jan 05, 2024 | Glenn Goddard | EVP, CHIEF FINANCIAL OFFICER | -5.37K | $29.46 | -$158.05K | SELL | -11.68% | 40.59K | Jan 03 | View |
| Jan 05, 2024 | Derek Hicks | EVP, CHIEF BUSINESS OFFICER | -3.88K | $29.46 | -$114.22K | SELL | -9.49% | 36.99K | Jan 03 | View |
| Jan 05, 2024 | James Basta | EVP, GENERAL COUNSEL | -3.81K | $29.46 | -$112.10K | SELL | -6.88% | 51.47K | Jan 03 | View |
| Jan 05, 2024 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | -4.61K | $29.50 | -$135.95K | SELL | -10.14% | 40.84K | Jan 03 | View |
| Nov 02, 2023 | Muna Bhanji | DIRECTOR | -265.00 | $23.90 | -$6.33K | SELL | -2.16% | 12.00K | Oct 31 | View |
| Aug 02, 2023 | Muna Bhanji | DIRECTOR | -265.00 | $42.33 | -$11.22K | SELL | -2.12% | 12.26K | Jul 31 | View |
| Jul 10, 2023 | Muna Bhanji | DIRECTOR | -1.87K | $39.30 | -$73.37K | SELL | -12.97% | 12.53K | Jul 06 | View |
| Jul 06, 2023 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | -360.00 | $40.51 | -$14.58K | SELL | -0.79% | 45.15K | Jul 03 | View |
| Jun 22, 2023 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | 0.00 | $28.63 | -$163.65K | SELL-OPTIONS | 0.00% | 45.15K | Jun 20 | View |
| Mar 03, 2023 | James Basta | EVP, GENERAL COUNSEL | 35.72K | $43.88 | -$47.74K | GRANT | 182.63% | 55.28K | Mar 01 - Mar 02 | View |
| Jan 06, 2023 | Laura SeppLorenzino | EVP, CHIEF SCIENTIFIC OFFICER | -4.84K | $37.82 | -$182.98K | SELL | -21.53% | 17.63K | Jan 04 - Jan 05 | View |
| Jan 06, 2023 | JOHN LEONARD | PRESIDENT AND CEO | -6.67K | $37.21 | -$248.30K | SELL | -0.80% | 825.24K | Jan 04 | View |
| Jan 06, 2023 | Derek Hicks | EVP, CHIEF BUSINESS OFFICER | -1.81K | $37.21 | -$67.42K | SELL | -9.48% | 17.31K | Jan 04 | View |
| Jan 06, 2023 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | -2.57K | $37.21 | -$95.78K | SELL | -9.11% | 25.69K | Jan 04 | View |
| Jan 06, 2023 | Glenn Goddard | EVP, CHIEF FINANCIAL OFFICER | -2.43K | $37.21 | -$90.31K | SELL | -13.61% | 15.40K | Jan 04 | View |
| Jan 06, 2023 | Eliana Clark | EVP, CHIEF TECHNICAL OFFICER | -2.03K | $37.65 | -$76.36K | SELL | -12.29% | 14.47K | Jul 01 - Jan 04 | View |
| Jan 06, 2023 | James Basta | EVP, GENERAL COUNSEL | -1.14K | $37.21 | -$42.34K | SELL | -5.50% | 19.56K | Jan 04 | View |
| Mar 04, 2022 | JOHN LEONARD | PRESIDENT AND CEO | 46.34K | $112.25 | -$279.85K | SELL-OPTIONS | 5.96% | 824.07K | Jan 01 - Mar 01 | View |
| Mar 03, 2022 | Laura SeppLorenzino | EVP, CHIEF SCIENTIFIC OFFICER | 16.17K | $112.25 | -$128.86K | SELL-OPTIONS | 656.44% | 18.63K | Jan 01 - Mar 01 | View |
| Mar 03, 2022 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | 15.95K | $112.24 | -$117.96K | SELL-OPTIONS | 181.56% | 24.74K | Jan 01 - Mar 01 | View |
| Mar 03, 2022 | Glenn Goddard | EVP, CHIEF FINANCIAL OFFICER | 14.77K | $112.24 | -$113.70K | SELL-OPTIONS | ∞ | 14.77K | Jan 01 - Mar 01 | View |
| Nov 09, 2021 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | 0.00 | $72.67 | -$288.25K | SELL-OPTIONS | 0.00% | 8.71K | Nov 05 | View |
| Oct 15, 2021 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | 0.00 | $70.53 | -$277.96K | SELL-OPTIONS | 0.00% | 8.71K | Oct 14 | View |
| Oct 13, 2021 | John Crowley | DIRECTOR | 0.00 | $69.19 | -$251.80K | SELL-OPTIONS | 0.00% | 2.09K | Oct 11 | View |
| Oct 07, 2021 | John Crowley | DIRECTOR | 0.00 | $74.68 | -$1.12M | SELL-OPTIONS | 0.00% | 2.09K | Oct 05 | View |
| Sep 23, 2021 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | 0.00 | $81.22 | -$329.26K | SELL-OPTIONS | 0.00% | 791.00 | Sep 21 | View |
| Sep 09, 2021 | Glenn Goddard | EVP, CHIEF FINANCIAL OFFICER | 0.00 | $97.35 | -$576.41K | SELL-OPTIONS | 0.00% | 0.00 | Sep 07 | View |
| Sep 01, 2021 | JOHN LEONARD | PRESIDENT AND CEO | 0.00 | $88.95 | -$17.45M | SELL-OPTIONS | 0.00% | 777.72K | Aug 30 - Sep 01 | View |
| Sep 01, 2021 | Laura SeppLorenzino | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $84.42 | -$13.66M | SELL-OPTIONS | 0.00% | 2.39K | Aug 30 | View |
| Sep 01, 2021 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | 0.00 | $85.33 | -$349.01K | SELL-OPTIONS | 0.00% | 791.00 | Aug 30 | View |
| Sep 01, 2021 | Glenn Goddard | EVP, CHIEF FINANCIAL OFFICER | 0.00 | $89.22 | -$4.21M | SELL-OPTIONS | 0.00% | 0.00 | Aug 30 - Aug 31 | View |
| Aug 25, 2021 | JOHN LEONARD | PRESIDENT AND CEO | 0.00 | $82.71 | -$3.76M | SELL-OPTIONS | 0.00% | 777.72K | Aug 23 | View |
| Aug 20, 2021 | JOHN LEONARD | PRESIDENT AND CEO | 0.00 | $82.34 | -$3.13M | SELL-OPTIONS | 0.00% | 777.72K | Aug 19 | View |
| Aug 11, 2021 | David Lebwohl | EVP, CHIEF MEDICAL OFFICER | 0.00 | $88.34 | -$363.43K | SELL-OPTIONS | 0.00% | 791.00 | Aug 09 | View |
| Aug 06, 2021 | Laura SeppLorenzino | EVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $75.82 | -$3.25M | SELL-OPTIONS | 0.00% | 2.39K | Aug 04 | View |
| Aug 06, 2021 | Glenn Goddard | EVP, CHIEF FINANCIAL OFFICER | 0.00 | $85.16 | -$2.64M | SELL-OPTIONS | 0.00% | 0.00 | Aug 05 | View |
| Jun 29, 2021 | FRANCOIS JEAN FORMELA | DIRECTOR | -553.38K | $132.73 | -$73.45M | SELL | -98.22% | 10.00K | Jun 28 | View |
| Jun 15, 2021 | FRANCOIS JEAN FORMELA | DIRECTOR | -201.72K | $87.04 | -$17.56M | SELL | -26.37% | 563.38K | Jun 11 - Jun 14 | View |
| Apr 30, 2021 | FRANCOIS JEAN FORMELA | DIRECTOR | -4.51K | $85.43 | -$385.55K | SELL | -0.59% | 765.10K | Apr 29 | View |
| Apr 28, 2021 | FRANCOIS JEAN FORMELA | DIRECTOR | -342.96K | $85.96 | -$29.48M | SELL | -30.83% | 769.61K | Apr 26 - Apr 28 | View |
| Apr 07, 2021 | FRANCOIS JEAN FORMELA | DIRECTOR | -800.00 | $84.98 | -$67.98K | SELL | -0.07% | 1.11M | Apr 05 | View |
| Apr 06, 2021 | CAROLINE DORSA | DIRECTOR | 0.00 | $44.29 | -$568.40K | SELL-OPTIONS | 0.00% | 5.41K | Apr 05 | View |
| Apr 02, 2021 | JOHN LEONARD | PRESIDENT AND CEO | 32.83K | $48.89 | -$2.19M | SELL-OPTIONS | 4.57% | 751.78K | Apr 01 | View |
| Apr 02, 2021 | Jose Rivera | EVP, GENERAL COUNSEL | 46.55K | $47.49 | -$2.95M | SELL-OPTIONS | 12.31% | 424.60K | Apr 01 | View |
| Mar 01, 2021 | FRANCOIS JEAN FORMELA | DIRECTOR | -501.94K | $60.29 | -$30.26M | SELL | -31.07% | 1.11M | Feb 26 | View |
| Feb 09, 2021 | Jose Rivera | EVP, GENERAL COUNSEL | 9.51K | $46.65 | -$477.48K | SELL-OPTIONS | 2.57% | 380.13K | Feb 09 | View |
| Feb 09, 2021 | JOHN LEONARD | PRESIDENT AND CEO | 45.73K | $40.62 | -$2.73M | SELL-OPTIONS | 6.79% | 718.95K | Feb 05 - Feb 09 | View |
| Feb 03, 2021 | JOHN LEONARD | PRESIDENT AND CEO | 139.31K | $41.21 | -$7.15M | SELL-OPTIONS | 26.09% | 673.22K | Feb 01 - Feb 03 | View |
| Feb 03, 2021 | Jose Rivera | EVP, GENERAL COUNSEL | 54.34K | $36.84 | -$2.44M | SELL-OPTIONS | 17.18% | 370.62K | Feb 01 | View |
| Jan 05, 2021 | JOHN LEONARD | PRESIDENT AND CEO | 8.14K | $55.86 | -$348.51K | SELL-OPTIONS | 1.55% | 533.90K | Dec 31 - Jan 05 | View |
| Jan 05, 2021 | ANDREW SCHIERMEIER | EVP, CHIEF OPERATING OFFICER | 3.42K | $55.86 | -$76.92K | SELL-OPTIONS | 25.79% | 16.66K | Dec 31 - Jan 05 | View |
| Jan 05, 2021 | Jose Rivera | EVP, GENERAL COUNSEL | 2.71K | $55.86 | -$116.08K | SELL-OPTIONS | 0.87% | 314.20K | Dec 31 - Jan 05 | View |
| Dec 18, 2020 | PERRY KARSEN | — | 0.00 | $36.00 | -$3.12M | OPTION EXERCISE | 0.00% | 5.00K | Dec 17 | View |
| Dec 03, 2020 | Jose Rivera | — | 1.64K | $26.04 | -$59.13K | OPTION EXERCISE | 0.53% | 310.92K | Dec 01 | View |
| Nov 27, 2020 | JOHN LEONARD | — | 0.00 | $27.37 | -$783.90K | OPTION EXERCISE | 0.00% | 525.77K | Nov 27 | View |
| Nov 25, 2020 | JOHN LEONARD | — | 0.00 | $21.41 | -$1.46M | OPTION EXERCISE | 0.00% | 525.77K | Nov 25 | View |
| Nov 18, 2020 | JOHN LEONARD | — | 0.00 | $24.29 | -$388.40K | OPTION EXERCISE | 0.00% | 525.77K | Nov 16 | View |
| Nov 18, 2020 | Jose Rivera | — | 4.76K | $21.30 | -$134.47K | OPTION EXERCISE | 1.56% | 309.28K | Nov 16 - Nov 18 | View |
| Nov 06, 2020 | Jose Rivera | — | 1.64K | $20.94 | -$24.79K | OPTION EXERCISE | 0.54% | 304.52K | Nov 04 | View |
| Nov 06, 2020 | JOHN LEONARD | — | 0.00 | $16.41 | -$958.50K | OPTION EXERCISE | 0.00% | 525.77K | Nov 04 | View |
| Oct 16, 2020 | Jose Rivera | — | 4.38K | $15.52 | -$67.58K | OPTION EXERCISE | 1.47% | 302.89K | Oct 15 | View |
| Oct 09, 2020 | JOHN LEONARD | — | 0.00 | $14.33 | -$75.00K | OPTION EXERCISE | 0.00% | 525.77K | Oct 07 | View |
| Sep 17, 2020 | Jose Rivera | — | 4.38K | $13.93 | -$49.84K | OPTION EXERCISE | 1.49% | 298.50K | Sep 15 | View |
| Sep 03, 2020 | JOHN LEONARD | — | 0.00 | $14.33 | -$75.00K | OPTION EXERCISE | 0.00% | 525.77K | Sep 01 | View |
| Aug 20, 2020 | Jose Rivera | EVP, GENERAL COUNSEL | 4.38K | $13.91 | -$49.62K | SELL-OPTIONS | 1.51% | 294.12K | Aug 18 | View |
| Aug 07, 2020 | JOHN LEONARD | — | 0.00 | $14.33 | -$75.00K | OPTION EXERCISE | 0.00% | 525.77K | Aug 06 | View |
| Jul 17, 2020 | Jose Rivera | — | 4.38K | $14.77 | -$59.16K | OPTION EXERCISE | 1.54% | 289.73K | Jul 15 | View |
| Jul 02, 2020 | JOHN LEONARD | — | 0.00 | $14.33 | -$75.00K | OPTION EXERCISE | 0.00% | 525.77K | Jul 01 | View |
| Jun 18, 2020 | Jose Rivera | — | 4.38K | $13.91 | -$49.62K | OPTION EXERCISE | 1.57% | 284.49K | Jun 16 | View |
| Jun 05, 2020 | JOHN LEONARD | — | 0.00 | $14.33 | -$75.00K | OPTION EXERCISE | 0.00% | 525.77K | Jun 03 | View |
| May 28, 2020 | Jose Rivera | — | 4.38K | $14.02 | -$50.79K | OPTION EXERCISE | 1.59% | 280.11K | May 26 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.